IFN-γ and TNF-α differentially regulate immunomodulation by murine mesenchymal stem cells

被引:370
作者
English, Karen
Barry, Frank P.
Field-Corbett, Ciara P.
Mahon, Bernard P. [1 ]
机构
[1] Natl Univ Ireland Maynooth, Inst Immunol, Mucosal Immunol Lab, Maynooth, Kildare, Ireland
[2] Natl Univ Ireland Univ Coll Galway, REMEDI, Natl Ctr Biomed Engn Sci, Galway, Ireland
[3] Natl Univ Ireland Maynooth, Inst Immunol, Epithelial Immunobiol Lab, Maynooth, Kildare, Ireland
基金
爱尔兰科学基金会;
关键词
mesenchymal stem cell; immunosuppression; IFN-gamma; TNF-alpha; prostaglandin; IDO;
D O I
10.1016/j.imlet.2007.04.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Murine mesenchymal stem cells (MSC) have the ability to inhibit allogeneic immune responses. Two different mechanisms, either cell contact-dependent or independent, have been proposed to account for this immunosuppression. The focus of this study was to elucidate the involvement of soluble suppressive factors secreted by murine MSC in an inflammatory setting, and their role in MSC immunomodulation. In a non-inflammatory environment, bone marrow derived murine MSC constitutively expressed low levels of COX-2, PGE-2, TGF-beta 1 and HGF, but not IL-10, PD-1, PD-L1 or PD-L2. These MSC were able to significantly reduce alloantigen driven proliferation in mixed lymphocyte reactions as well as mitogen driven proliferation. The pro-inflammatory cytokines IFN-gamma and TNF-alpha did not ablate MSC mediated immunosuppression. MSC expression of PGE-2, IDO and PD-L1 was differentially regulated by these cytokines. COX-2 and PGE-2 expression by MSC were upregulated by both IFN-gamma and TNF-alpha, and using a biochemical inhibitor this was shown to have an essential, non-redundant role in modulating alloantigen-driven proliferation. However, the surface expression of PD-L1 was induced by IFN-gamma but not TNF-alpha and similarly functional IDO expression was only induced by IFN-gamma stimulation. Blocking studies using neutralising antibodies and biochemical antagonists revealed that while PD-L1 induction was not essential, IDO expression was a prerequisite for IFN-gamma mediated MSC immunomodulation. These data demonstrate that murine MSC expression of immunomodulatory factors dramatically changes in a pro-inflammatory environment and that IFN-gamma in particular has an important role in regulating MSC immunomodulatory factor expression. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:91 / 100
页数:10
相关论文
共 54 条
[1]   Human mesenchymal stem cells modulate allogeneic immune cell responses [J].
Aggarwal, S ;
Pittenger, MF .
BLOOD, 2005, 105 (04) :1815-1822
[2]  
Angoulvant D, 2004, BIORHEOLOGY, V41, P469
[3]  
[Anonymous], 2006, J CELL SCI
[4]   Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway [J].
Augello, A ;
Tasso, R ;
Negrini, SM ;
Amateis, A ;
Indiveri, F ;
Cancedda, R ;
Pennesi, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (05) :1482-1490
[5]   Mesenchymal stem cells: clinical applications and biological characterization [J].
Barry, FP ;
Murphy, JM .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (04) :568-584
[6]   Immunogenicity of adult mesenchymal stem cells: Lessons from the fetal allograft [J].
Barry, FP ;
Murphy, JM ;
English, K ;
Mahon, BP .
STEM CELLS AND DEVELOPMENT, 2005, 14 (03) :252-265
[7]  
Barry Frank P., 2003, Birth Defects Research, V69, P250, DOI 10.1002/bdrc.10021
[8]   Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J].
Bartholomew, A ;
Sturgeon, C ;
Siatskas, M ;
Ferrer, K ;
McIntosh, K ;
Patil, S ;
Hardy, W ;
Devine, S ;
Ucker, D ;
Deans, R ;
Moseley, A ;
Hoffman, R .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :42-48
[9]   Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness [J].
Beyth, S ;
Borovsky, Z ;
Mevorach, D ;
Liebergall, M ;
Gazit, Z ;
Aslan, H ;
Galun, E ;
Rachmilewitz, J .
BLOOD, 2005, 105 (05) :2214-2219
[10]  
Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO